首页> 美国卫生研究院文献>Haematologica >A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis
【2h】

A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis

机译:竞争性的酶联免疫吸附法专门针对鼠hepcidin-1的研究:与建立的铁稳态平衡的新型模型中的肝mRNA表达相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mice have been essential for distinguishing the role of hepcidin in iron homeostasis. Currently, investigators monitor levels of murine hepatic hepcidin-1 mRNA as a surrogate marker for the bioactive hepcidin protein itself. Here, we describe and validate a competitive, enzyme-linked immunosorbent assay that quantifies hepcidin-1 in mouse serum and urine. The assay exhibits a biologically relevant lower limit of detection, high precision, and excellent linearity and recovery. We also demonstrate correlation between serum and urine hepcidin-1 values and validate the competitive enzyme-linked immunosorbent assay by analyzing plasma hepcidin response of mice to physiological challenges, including iron deficiency, iron overload, acute blood loss, and inflammation. Furthermore, we analyze multiple murine genetic models of iron dysregulation, including β-thalassemia intermedia (Hbbth3/+), hereditary hemochromatosis (Hfe−/−, Hjv−/−, and Tfr2Y245X/Y245X), hypotransferrinemia (Trfhpx/hpx), heterozygous transferrin receptor 1 deficiency (Tfrc+/−) and iron refractory iron deficiency anemia (Tmprss6−/− and Tmprss6hem8/hem8). Novel compound iron metabolism mutants were also phenotypically characterized here for the first time. We demonstrate that serum hepcidin concentrations correlate with liver hepcidin mRNA expression, transferrin saturation and non-heme liver iron. In some circumstances, serum hepcidin-1 more accurately predicts iron parameters than hepcidin mRNA, and distinguishes smaller, statistically significant differences between experimental groups.
机译:小鼠对于区分铁调素中铁调素的作用至关重要。目前,研究人员监测鼠肝hepcidin-1 mRNA的水平,作为生物活性hepcidin蛋白本身的替代标记。在这里,我们描述并验证了一种竞争性的酶联免疫吸附测定,该测定可以定量小鼠血清和尿液中的hepcidin-1。该测定法具有生物学相关的检测下限,高精度,出色的线性和回收率。我们还证明了血清和尿中hepcidin-1值之间的相关性,并通过分析小鼠血浆hepcidin对生理挑战(包括铁缺乏症,铁超载,急性失血和炎症)的反应来验证竞争性酶联免疫吸附测定。此外,我们分析了多种铁代谢失调的小鼠遗传模型,包括中间β地中海贫血(Hbb th3 / + ),遗传性血色素沉着病(Hfe -// ,Hjv -/-和Tfr2 Y245X / Y245X ),低转铁蛋白血症(Trf hpx / hpx ),杂合转铁蛋白受体1缺陷(Tfrc +/- )和铁难治性缺铁性贫血(Tmprss6 -/-和Tmprss6 hem8 / hem8 )。还首次在表型上表征了新型复合铁代谢突变体。我们证明血清hepcidin浓度与肝hepcidin mRNA表达,转铁蛋白饱和度和非血红素肝铁相关。在某些情况下,血清hepcidin-1比hepcidin mRNA更准确地预测铁参数,并区分实验组之间较小的,统计学上显着的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号